GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vanda Pharmaceuticals Inc (STU:VM4) » Definitions » FCF Yield %

Vanda Pharmaceuticals (STU:VM4) FCF Yield % : -6.74 (As of Dec. 13, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Vanda Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Vanda Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-16.5 Mil, and Market Cap is €256.4 Mil. Therefore, Vanda Pharmaceuticals's FCF Yield % for today is -6.74%.

The historical rank and industry rank for Vanda Pharmaceuticals's FCF Yield % or its related term are showing as below:

STU:VM4' s FCF Yield % Range Over the Past 10 Years
Min: -21.53   Med: 2.08   Max: 16.99
Current: -6.74


During the past 13 years, the highest FCF Yield % of Vanda Pharmaceuticals was 16.99%. The lowest was -21.53%. And the median was 2.08%.

STU:VM4's FCF Yield % is ranked better than
62.97% of 1507 companies
in the Biotechnology industry
Industry Median: -12.65 vs STU:VM4: -6.74

Vanda Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2024 was -30.94%.


Vanda Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Vanda Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanda Pharmaceuticals FCF Yield % Chart

Vanda Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.07 7.13 7.05 7.71 5.21

Vanda Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.31 -6.69 13.43 -8.38 -21.80

Competitive Comparison of Vanda Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Vanda Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vanda Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vanda Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Vanda Pharmaceuticals's FCF Yield % falls into.



Vanda Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Vanda Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=11.388 / 218.6311
=5.21%

Vanda Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-13.282 * 4 / 243.719498
=-21.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vanda Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Vanda Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Vanda Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vanda Pharmaceuticals Business Description

Traded in Other Exchanges
Address
2200 Pennsylvania Avenue NW, Suite 300 E, Washington, DC, USA, 20037
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

Vanda Pharmaceuticals Headlines

No Headlines